Canton Strategic Holdings (CNTN) Accounts Payables (2020 - 2026)
Canton Strategic Holdings posted quarterly Accounts Payables of $402311.0 for Q1 2026, down 52.0% year-on-year from $838184.0 in Q1 2025, and down 63.1% on a QoQ basis from $1.1 million in Q4 2025.
Canton Strategic Holdings (CNTN) has 7 years of Accounts Payables data on file, last reported at $402311.0 in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables fell 52.0% year-over-year to $402311.0; the trailing twelve-month figure through Mar 2026 stood at $402311.0 (down 52.0% YoY), and the FY2025 full-year result was $1.1 million, changed 0.06% from the prior year.
- Accounts Payables for Q1 2026 stood at $402311.0, down from $1.1 million in the prior quarter.
- Across five years, Accounts Payables topped out at $1.1 million in Q2 2023 and bottomed at $402311.0 in Q1 2026.
- The 5-year median for Accounts Payables is $784029.0 (2024), against an average of $821553.8.
- The widest annual swing landed in 2023, when Accounts Payables jumped 112.11%; it then sank 52.0% in 2026.
- A 5-year view of Accounts Payables shows it stood at $954505.0 in 2022, then retreated by 4.81% to $908577.0 in 2023, then advanced by 19.93% to $1.1 million in 2024, then grew by 0.06% to $1.1 million in 2025, then tumbled by 63.1% to $402311.0 in 2026.
- The last three Accounts Payables figures came in at $402311.0 (Q1 2026), $1.1 million (Q4 2025), and $659254.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 8.64 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | 402,311.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 402,311.00 |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 659,254.00 |
| Jun 30, 2025 | 770,610.00 |
| Mar 31, 2025 | 838,184.00 |
| Dec 31, 2024 | 1.09 Mn |
| Sep 30, 2024 | 783,839.00 |
| Jun 30, 2024 | 784,029.00 |
| Mar 31, 2024 | 993,244.00 |
| Dec 31, 2023 | 908,577.00 |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | 718,990.00 |
| Dec 31, 2022 | 954,505.00 |
| Sep 30, 2022 | 536,838.00 |
| Jun 30, 2022 | 559,529.00 |
| Mar 31, 2022 | 597,455.00 |
| Dec 31, 2021 | 1.46 Mn |
| Dec 31, 2020 | 514,828.00 |